by Igen BioLab Group | Jun 26, 2019 | News, Sin categoría
New research from the University of Virginia Cancer Center suggests that inflamed and unhealthy bowels cause breast cancer to become much more invasive and spread more quickly to other parts of the body. Melanie Rutkowski, PhD, of the Department of Microbiology,...
by Igen BioLab Group | Jun 20, 2018 | Events, Sin categoría
A collaboration between the University of Bath and University College London has revealed that microbes act like shrewd economists when cooperating. When they find themselves in groups with mostly relatives they contribute heavily to cooperation, which benefits the...
by Igen BioLab Group | Jun 16, 2018 | Sin categoría
Veena Taneja, PhD, associate professor of immunology in the Department of Immunology and Rheumatology at the Mayo Clinic in Rochester, Minnesota, discussed in this interview the latest insights about the association between the gut microbiome and Rheumatoid Arthritis....
by Igen BioLab Group | Jun 12, 2018 | Sin categoría
The intestinal microbiome seems to influence in the functioning of some anti-cancer drugs. But, is science mature to perform this type of clinical trials? In recent decades, scientists have linked the composition of mycrobiota with dozens of diseases ranging from...
by Igen BioLab Group | Jun 10, 2018 | Sin categoría
The level of diversity of the good bacteria; in our digestive systems has been found to be linked to a feature of cardiovascular disease (hardening of the arteries) in new research by experts at the University of Nottingham and King’s College London. Now for the first...
by Igen BioLab Group | Jun 8, 2018 | Sin categoría
University of Chicago Medicine researchers report that specific microbiome assemblages can boost the response rate to immunotherapy for patients being treated for advanced melanoma. Their study (”The Commensal Microbiome Is Associated with Anti–PD-1 Efficacy in...
